Australia's largest stock trading and investment forum Australia's #1 stock forum

NEA

0.00%

$2.10 nearmap ltd

Next update?, page-17

First 17 Last

Share
Profile

Follow
birdman29

29,045 Posts.

486

03/05/17

12:19

Post #: 24437124
Share

Originally posted by crystalblue ↑

Nearmap has truely shaken Eagleview in the US, and if anyone does a rough estimate on just how much Eagleview have spend on Spookfish (and now buying Omniearth) you will end up with a figure well over $15 million dollars.

Even if Eagleview is just investing $15 million to defend themselves against a Nearmap US entry, this logically implies that Eagleview actually sees Nearmap as a real threat that will eventually erode their existing market share by many times their current $15 million investment.

Although we can't be certain as to what Eagleview has estimated in terms of what Nearmap will take from their current market share. I believe at some stage in the past, someone in Eagleview would have to create a solid business case that highlighted a lost of market share of at least $100 to $150 million to Nearmap to justify their current $15 million investment.

Of course, we may never know the initial Eagleview business case details, however moving forward I believe Eagleview's ongoing spending will proportionally give us a silient measure in just how much market share Nearmap could win from Eagleview.

Expand

And... There is always a chance...that a "Large" US Company could one day make an offer NEA could not refuse !!

3.00 Dollars per Share would be nice !

NEA Price at posting: 50.0¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

FG1

Flynn Gold reaches milestone exploration target for Golden Ridge

Trump is President Again: What Does This Mean for Crypto?

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive

HotCopper Highlights: Your most watched and most discussed stocks this week

IMU

Imugene kicks off Australian trial for blood cancer treatment

MMI

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

UBI

Universal Biosensors flat despite fresh deal with US medical product distributor